U.S. Mission Türkiye, Public Diplomacy Grants Program

Bureau of European and Eurasian Affairs
U.S. Mission Türkiye of the U.S. Department of State is pleased to announce that funding is available through its Public Diplomacy Grants Program. U.S. Mission Türkiye invites proposals for...more

Switzer Research Fellowships Program

Administration for Community Living
The purpose of the Switzer Research Fellowships program is to build research capacity by providing support to highly qualified individuals, including individuals with disabilities, to conduct...more

ROSES 2022: Sustainable Land Imaging-Technology

NASA Headquarters
Please note that this program requests optional Notices of Intent, which are due via NSPIRES by January 3, 2023. See the full posting on NSPIRES for details. Proposers must retrieve the instructions...more

NOAA SBIR FY 2023 Phase I

Department of Commerce
The Department of Commerce (DOC) National Oceanic and Atmospheric Administration (NOAA) invites small businesses to submit research proposals under this NOFO. Firms with the capability to conduct...more

Cooperative Agreement to Support Regulatory Research Related to the 2023 Prescription Drug User Fee Act

Food and Drug Administration
The primary objective of this effort is to provide supporting research, identify key issues, and convene appropriate subject matter experts to help inform major regulatory science initiatives related...more

Designing and performing a virtual bioequivalence trial for physiologically-based pharmacokinetic and other mechanism-based models

Food and Drug Administration
The purpose of this funding opportunity is to develop a workflow for designing and performing a reliable virtual bioequivalence study by leveraging a physiologically-based pharmacokinetic (PBPK)...more

Novel approaches to support therapeutic development in ultra-rare cancers

Food and Drug Administration
The purpose of this NOFO is to encourage new approaches to support therapeutic development in ultra-rare pediatric and adult cancers, including molecularly-defined subsets of more common...more

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Food and Drug Administration
The purpose of this research is to systematically evaluate the diastereomeric composition of LEQVIO (Inclisiran), an FDA-approved, N-acetylgalactosamine (GalNAc)-conjugated siRNA drug, and to...more

Population Pharmacokinetic Modeling of Systemic Pharmacokinetic Data to Inform Bioequivalence in Regional Lung Exposure (U01) Clinical Trial Not Allowed

Food and Drug Administration
Orally Inhaled Drug Products (OIDPs) are complex drug-device combination products. To establish bioequivalence for locally acting OIDPs, FDA is currently using a weight-of-evidence approach which...more